1Gurney J G, Ross J A, Wall D A, et al. Infant cancer in the U. S: histology-specific incidence and trends,1973 to 1992. J Padiatr Hematol Oncol, 1997, 19:428-432.
2Bresters D, Reus A C, Veerman, et al. Congenital leukemia:: the Dutch experience and review of the literature. Br J Haematol, 2002, 117:513-524.
3Hunger S P, Cleary, Repp R, et al. Backtracking leukemia to birth.: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA, 1997, 94:13950-13954.
4Reaman G H, Sposto R, Sensel M G, et al. Treatment outcome and prognostic factors for infants with acutelymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol, 1999,19:35-42.
5Pui C H, Kalwinsky D K, Schell M J, et al. Acute nonlymphoblastic leukemia in infants:Clinical presentation and outcome. J Clin Oncol, 1988, 6:1008-1013.
6Frankel L S, Ochs J, Shuster J J, et al. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience. J Pediatric Hematol Oncol, 1997, 19:35-42.
7Dordelmann M, Reiter A, Borkhardt A, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood,1999, 94:1209-1217.
8Lauer S J, Camitta B M, Leventhal B G, et al. Intentive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: a Pediatric Oneology Group pilot study. J Pediatric Hematol Oncol, 1998, 20:229-233.
9Stevens R F, Hann J M, Wheatley K, Gray R G.Marked improvements in outcome with chemotherapy alone in pediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC childhood leukemia working party. Br J Haematol, 1998, 101:130-140.
10Zipursky A, Brown E, Christenen H, et al. Leukemia and/or myleoproliferative syndrome in neonates with Done syndrome. Semin Perinatol, 1997, 21 : 97- 101.
2Kawasaki H, Isoyama K, Eguchi M, et al. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy : results of the Japan Infant Leukemia Study Group. Blood, 2001 ;98 (13): 3589-3594.
3Ishii E, Kawasaki H, Isoyama K, et al. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma, 2003 ;44 ( 5 ) : 741-748.
4Pui CH, Raimondi SC, Srivastava DK, et al. Prognostic factors in infants with acute myeloid leukemia. Leukemia, 2000; 14 (4): 684-687.
5Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia ( Interfant-99 ) : an observational study and a multicentre randomised trial. Lancet, 2007 ;370(9583) :240-250.
6Dordelmann M, Reiter A, Borkhardt A, et al. Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia. Blood, 1999 ; 194 (4) : 1209-1217.
7Nagayama J, Tomizawa D, Koh K, et al. Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group. Blood, 2006 ; 107 (12) :4663-4665.
8Hilden JM. , Patricia A, Dinndorf, et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants:report on CCG1953 from the Children ' s Oncology Group. Blood, 2006 ; 108 ( 2 ) : 441-451.
9Kosaka Y, Koh K, Kinukawa N, et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements:outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood, 2004 ; 104 (12) :3527-3534.
